Phase I study of temsirolimus (CCI-779) and sorafenib in recurrent glioblastoma: North central cancer treatment group (NCCTG) N0572

被引：0

作者：

Schiff, David ^{[1
]}

Sarkaria, Jann ^{[2
]}

Decker, Paul ^{[2
]}

Buckner, Jan ^{[2
]}

Galanis, Evanthia ^{[2
]}

Dancey, Janet ^{[3
]}

Giannini, Caterina ^{[2
]}

Brown, Paul ^{[2
]}

Wiesenfeld, Martin ^{[4
]}

Jaeckle, Kurt ^{[5
]}

机构：

[1] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA

[2] Mayo Clin, Rochester, MN USA

[3] Natl Canc Inst, Bethesda, MD USA

[4] Cedar Rapids Oncol Project, Cedar Rapids, IA USA

[5] Mayo Clin, Jacksonville, FL 32224 USA

来源：

NEURO-ONCOLOGY | 2007年 / 9卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：518 / 518

页数：1

共 50 条

[41] NCCTG N0272: PHASE II TRIAL OF IMATINIB MESYLATE; (GLEEVEC; STI571) IN TREATMENT OF RECURRENT OLIGODENDROGLIOMA AND MIXED OLIGOASTROCYTOMA: A NORTH CENTRAL CANCER TREATMENT GROUP STUDY [J].

Jaeckle, Kurt A. ;

Anderson, S. K. ;

Kosel, Matt ;

Sarkaria, Jann ;

Brown, Paul ;

Flynn, P. J. ;

Buckner, Jann C. ;

Galanis, Eva .

NEURO-ONCOLOGY, 2011, 13 :89-89

[42] Relationship of administration of enzyme-inducing anticonvulsants (EIAC) to survival in patients with glioblastoma: A north central cancer treatment group (NCCTG) study [J].

Jaeckle, K ;

Ballman, K ;

Uhm, J ;

O'Fallon, J ;

Schomberg, P ;

Scheithauer, B ;

Giannini, C ;

Flynn, P ;

Buckner, J .

NEURO-ONCOLOGY, 2004, 6 (04) :376-376

[43] Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) [J].

Jaeckle, Kurt A. ;

Anderson, S. K. ;

Twohy, Erin L. ;

Dixon, Jesse G. ;

Giannini, Caterina ;

Jenkins, Robert ;

Egorin, Merrill J. ;

Sarkaria, Jann N. ;

Brown, Paul D. ;

Flynn, P. J. ;

Schwerkoske, John ;

Buckner, Jan C. ;

Galanis, Evanthia .

JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (03) :573-581

[44] Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) [J].

Kurt A. Jaeckle ;

S. K. Anderson ;

Erin L. Twohy ;

Jesse G. Dixon ;

Caterina Giannini ;

Robert Jenkins ;

Merrill J. Egorin ;

Jann N. Sarkaria ;

Paul D. Brown ;

P. J. Flynn ;

John Schwerkoske ;

Jan C. Buckner ;

Evanthia Galanis .

Journal of Neuro-Oncology, 2019, 143 :573-581

[45] NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial. [J].

Ma, Daniel ;

Galanis, Evanthia ;

Schiff, David ;

Wu, Wenting ;

Peller, Patrick J. ;

Giannini, Caterina ;

Brown, Paul D. ;

Uhm, Joon H. ;

McGraw, Steven ;

Jaeckle, Kurt A. ;

Flynn, Patrick J. ;

Buckner, Jan C. ;

Sarkaria, Jann Nagina .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

[46] Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) [J].

Kurt A. Jaeckle ;

S. K. Anderson ;

Erin L. Twohy ;

Jesse G. Dixon ;

Caterina Giannini ;

Robert Jenkins ;

Merrill J. Egorin ;

Jann N. Sarkaria ;

Paul D. Brown ;

P. J. Flynn ;

John Schwerkoske ;

Jan C. Buckner ;

Evanthia Galanis .

Journal of Neuro-Oncology, 2019, 143 :583-583

[47] Correlation of response with survival endpoints in patients with newly diagnosed and recurrent glioblastoma (GBM) treated on prospective North Central Cancer Treatment Group (NCCTG) clinical trials [J].

Jaeckle, K. A. ;

Wu, W. ;

Kosel, M. ;

Flynn, P. J. ;

Buckner, J. C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[48] Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance) [J].

Galanis, Evanthia ;

Anderson, S. Keith ;

Twohy, Erin ;

Butowski, Nicholas A. ;

Hormigo, Adilia ;

Schiff, David ;

Omuro, Antonio ;

Jaeckle, Kurt A. ;

Kumar, Shaji ;

Kaufmann, Timothy J. ;

Geyer, Susan ;

Kumthekar, Priya U. ;

Campian, Jian ;

Giannini, Caterina ;

Buckner, Jan C. ;

Wen, Patrick Y. .

NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)

[49] Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study (vol 27, pg 2052, 2009) [J].

Galanis, E. ;

Jaeckle, K. A. ;

Maurer, M. J. ;

Reid, J. M. ;

Ames, M. M. ;

Hardwick, J. S. ;

Reilly, J. F. ;

Loboda, A. ;

Nebozhyn, M. ;

Fantin, V. R. ;

Richon, V. M. ;

Scheithauer, B. ;

Giannini, C. ;

Flynn, P. J. ;

Moore, D. F., Jr. ;

Zwiebel, J. ;

Buckner, J. C. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3262-3262

[50] Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177 [J].

Brown, Paul D. ;

Krishnan, Sunil ;

Sarkaria, Jann N. ;

Wu, Wenting ;

Jaeckle, Kurt A. ;

Uhm, Joon H. ;

Geoffroy, Francois J. ;

Arusell, Robert ;

Kitange, Gaspar ;

Jenkins, Robert B. ;

Kugler, John W. ;

Morton, Roscoe F. ;

Rowland, Kendrith M., Jr. ;

Mischel, Paul ;

Yong, William H. ;

Scheithauer, Bernd W. ;

Schiff, David ;

Giannini, Caterina ;

Buckner, Jan C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) :5603-5609

← 1 2 3 4 5 →